2 Reasons Why Skechers Is No Longer A Buy At Citi
Shares of lifestyle and performance footwear maker Skechers USA Inc (NYSE: SKX) are down nearly 30 percent since the start of 2018, and investors may want to reconsider buying the stock, as it has limited near-term upside, according to Citi.
The Analyst
Citi's Kate McShane downgraded Skechers from Buy to Neutral.
The Thesis
Skechers' ongoing concerns are well-known to the market and a bullish stance on the stock can no longer be justified for two reasons, McShane said in the downgrade note. (See her track record here.)
They are:
Concerns related to domestic wholesale growth.
Risks associated with higher SG&A at a time when the top line is weakening.
The two concerns could extend beyond the back half of 2018, which implies the potential for less near-term upside than previously expected, the analyst said.
The footwear maker made it clear it wants to prioritize long-term growth investments, including establishing international markets at the expense of short-term operating margin expansion, McShane said.
The bull case could be made again if Skechers shows signs of SG&A leverage or U.S. trends show a notable acceleration, she said.
Skechers' stock does look cheap at 14 times estimated 2019 EPS, which is a discount to its small- and mid-cap footwear peers at 17 times, the analyst said — but the stock is also trading in-line with its three-year average.
Price Action
Skechers shares were down 1.57 percent at $26.88 at the time of publication Tuesday.
Related Links:
Cowen Downgrades Skechers, Says Shoemaker Faces Forex, Inventory Pressures
After Skechers Issues Weak Guidance, Wells Fargo Predicts First Annual EPS Decline Since 2011
Latest Ratings for SKX
Oct 2018 | Citigroup | Downgrades | Buy | Neutral |
Sep 2018 | Cowen & Co. | Downgrades | Outperform | Market Perform |
Aug 2018 | Buckingham | Maintains | Buy | Buy |
View More Analyst Ratings for SKX
View the Latest Analyst Ratings
See more from Benzinga
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
